Table 1.
Method | Working Principle | Target | Correlation Range | Detection Limit | Ref |
---|---|---|---|---|---|
PSPR | Site-directed antibody immobilization based on protein A/G | C-reactive protein (CRP) | 1.2~80 ng/mL | 1.2 ng/mL | [27] |
Antibody immobilization based on EDC/NHS coulping | metalloproteinases-9 (MMP-9) | 10~200 ng/mL | 8 pg/mL | [28] | |
Site-directed antibody immobilization based on protein G | human growth hormone (hGH) | 66.4~199 ng/mL * | 21.9 ng/mL * | [29] | |
Sandwich assay based on AuNP-antibody conjugate | Carcinoembryonic Antigen (CEA) | 0~2.5 ng/mL | 17.8 pg/mL | [32] | |
Sandwich assay based on MWCNT-antibody conjugate | Tau Protein | 9.87~78.9 ng/mL * | 9.87 ng/mL * | [30] | |
Sandwich assay based on AuNP-antibody conjugate | Cardiac troponin T (cTnT) | 0.5~40 ng/mL | 0.5 ng/mL | [33] | |
LSPR | nanorods (GNR) functionalized with poly (N-isopropylacrylamide) (PNIPAAM) | Troponin-T (TnT) | 7.6~9.1 × 1011 fg/mL | 8.4 fg/mL | [34] |
LSPR band shift based on interparticle crosslinking | Staphylococcal enterotoxin A (SEA) | 0~250 ng/mL | 5 ng/mL | [35] | |
Core/shell nanoparticle Au@AgNPs and Ag@AuNPs | Staphylococcal enterotoxin A (SEA) | 0~500 ng/mL | 5.4 ng/mL | [36] | |
Single AuNP | α-fetoprotein (AFP) | 69~6.9 × 107 fg/mL * | 6.28 pg/mL * | [37] | |
Single AuNP | Carcinoembryonic antigen (CEA) | 180~1.8 × 108 fg/mL * | 16.9 pg/mL * | [37] | |
Single AuNP | Prostate specific antigen (PSA) | 28.4~2.84 × 106 fg/mL * | 284 fg/mL * | [37] | |
Au/Ag Bimetallic nanostructures modified with polydopamine films | Bovine serum albumin (BSA) | 0.01~100 ng/mL | 0.01 ng/mL | [38] | |
LSPR band shift based on the GNR etching resulted by TMB reaction | Carcinoembryonic antigen (CEA) | 0~60 ng/mL | 2.5 ng/mL | [39] | |
LSPR band shift based on the GNR etching resulted by TMB reaction | Prostate specific antigen (PSA) | 0~1275 pg/mL | 75 pg/mL | [39] |
* Some Values have been recalculated to express in terms of mL to provide better comparisons.